All posts tagged
Allergan makes a deal with Editas to License CRISPR Programs for Eye Disease
The Patent Office has Spoken: What does it Mean for CRISPR in Europe?
UPDATE: No Clear Winner in the CRISPR Patent Battle
Epigenetics Baby of Proteros is Signing Up with Top US Neurology Specialists
Live from Bio-Europe 2015: The product development challenges in the gene therapy field
Labiotech UG, All Rights Reserved -
Send this to friend